We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Boehringer Waves White Flag In Humira Patent Battle

Law360 (May 14, 2019, 4:33 PM EDT) -- Boehringer Ingelheim on Tuesday abandoned its long-shot assault on the patent fortress surrounding AbbVie Inc.'s immunosuppressant Humira, saying it would reluctantly join a long list of biosimilar makers that have agreed...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.